financetom
Business
financetom
/
Business
/
What's Going On With Commerce Company Liquidity Services Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Commerce Company Liquidity Services Stock Today?
Feb 3, 2025 6:55 AM

Shares of Liquidity Services, Inc. ( LQDT ) , a prominent player in global commerce focused on the circular economy, are trading lower in premarket trading on Monday.

The company announced the acquisition of Auction Software/Simple Auction Site. Terms of the transaction were not disclosed.

Founded by Rajesh Rajaram in 2015, Auction Software has created auction and marketplace platforms for various industries. Simple Auction Site (SAS) focuses on providing auction platforms for sports collectibles and fine wine.

This move establishes a new private-label and Software-as-a-Service (SaaS) division, Liquidity Services Software Solutions, Inc.

The acquisition is said to enhance Liquidity Services’ reach in the fragmented Circular Economy market and strengthen its software development resources, enabling the company to better support businesses of all sizes, from entrepreneurs to large multinational corporations.

Also Read: Walmart Canada To Invest About $3.8 Billion Over Five Years

“This acquisition aligns with our commitment to empower organizations to create value in the Circular Economy marketplace using innovative solutions,” said CEO Bill Angrick.

This acquisition is part of Liquidity Services’ strategy to offer tailored SaaS solutions to a growing client base, including businesses seeking forward, reverse, and hybrid online auctions.

Following the acquisition, Rajesh Rajaram, the founder of Auction Software, along with other key team members, will stay with the company to continue overseeing the development of auction platforms.

The deal is not anticipated to materially affect the overall financial performance of Liquidity Services ( LQDT ). The company held $155.5 million in cash and equivalents as of September 30, 2024.

Price Action: LQDT shares are trading lower by 7.10% at $34.65 in premarket at the last check Monday.

Read Next:

Jeep Maker Stellantis Unveils Organizational Overhaul; Stock Dips

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Albemarle concerned about lithium prices, but sees strong long-term demand
Albemarle concerned about lithium prices, but sees strong long-term demand
Jun 25, 2024
LAS VEGAS, June 25 (Reuters) - Albemarle, the world's largest lithium producer, is concerned about current prices for the metal used to make electric vehicle batteries but believes long-term demand will remain strong, an executive said on Tuesday. The company, which operates across the Americas, Asia and Australia, cut staff and paused expansion projects in January after prices fell more...
Update: Alnylam Pharmaceuticals Shares Rise as Heart Disease Candidate Meets Primary Endpoint in Late-Stage Study
Update: Alnylam Pharmaceuticals Shares Rise as Heart Disease Candidate Meets Primary Endpoint in Late-Stage Study
Jun 25, 2024
01:17 PM EDT, 06/25/2024 (MT Newswires) -- (Updates to reflect stock price movement in the headline and first paragraph.) Alnylam Pharmaceuticals ( ALNY ) shares were up more than 6% in recent Tuesday trading, a day after the company said vutrisiran, an investigational therapy for treating ATTR amyloidosis with cardiomyopathy, met its primary and secondary endpoints in a late-stage study....
What's Going On With Nikola Stock After Its Reverse Split?
What's Going On With Nikola Stock After Its Reverse Split?
Jun 25, 2024
Nikola Corporation ( NKLA ) shares are trading lower Tuesday after the stock began trading on a reverse split-adjusted basis.  The Details: Nikola ( NKLA ) effected a 1-for-30 reverse stock split after the closing bell Monday and shares commenced trading on a split-adjusted basis Tuesday morning. The company also filed a prospectus with the SEC regarding the offering of...
NervGen Pharma to Advance New Drug Candidate into Preclinical Proof-of-Concept Stage
NervGen Pharma to Advance New Drug Candidate into Preclinical Proof-of-Concept Stage
Jun 25, 2024
01:18 PM EDT, 06/25/2024 (MT Newswires) -- NervGen Pharma ( NGENF ) was last seen up 5% after the company on Tuesday said it plans to develop a new drug candidate, NVG-300, with a focus on three initial indications: ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). NVG-300 is a new biologic molecule discovered at NervGen. If...
Copyright 2023-2026 - www.financetom.com All Rights Reserved